Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
When Is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?
Mendenhall WM, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP.
Am J Clin Oncol. 2012 Jan 10. [Epub ahead of print]
Related citations
Clinical and biological significance of KISS1 expression in prostate cancer.
Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C.
Am J Pathol. 2012 Mar;180(3):1170-8. Epub 2012 Jan 6.
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.
Shirotake S, Miyajima A, Kosaka T, Tanaka N, Kikuchi E, Mikami S, Okada Y, Oya M.
Am J Pathol. 2012 Mar;180(3):1008-16. Epub 2012 Jan 6.
PCA: Prostate Cancer, Patient-Centred Approach or both?
Denis L, Joniau S, Bossi A, Baskin-Bey E, Fitzpatrick JM.
BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10859.x. [Epub ahead of print]
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.
Durand X, Xylinas E, Radulescu C, Haus-Cheymol R, Moutereau S, Ploussard G, Forgues A, Robert G, Vacherot F, Loric S, Allory Y, Ruffion A, de la Taille A.
BJU Int. 2012 Jan 5. doi: 10.1111/j.1464-410X.2011.10682.x. [Epub ahead of print]
The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.
Cooperberg MR, Hilton JF, Carroll PR.
Cancer. 2011 Nov 15;117(22):5039-46. doi: 10.1002/cncr.26169. Epub 2011 Jun 3.
Personalized treatment of prostate cancer based on inherited variations of steroid pathway-related genes.
Todenhöfer T, Schwentner C, Stenzl A.
Eur Urol. 2012 Jul;62(1):97-9. Epub 2012 Jan 3. No abstract available.
The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
Scattoni V, Raber M, Capitanio U, Abdollah F, Roscigno M, Angiolilli D, Maccagnano C, Gallina A, Saccà A, Freschi M, Doglioni C, Rigatti P, Montorsi F.
Eur Urol. 2011 Oct;60(4):834-41. Epub 2011 Jul 30.
High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G.
Eur Urol. 2011 Oct;60(4):842-9. Epub 2011 Apr 16.
Systemic blockade of the hyaluronan receptor for endocytosis prevents lymph node metastasis of prostate cancer.
Simpson MA, Weigel JA, Weigel PH.
Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27427. [Epub ahead of print]
The DDAH/NOS pathway in human prostatic cancer cell lines: antiangiogenic effect of L-NAME.
Vanella L, Di Giacomo C, Acquaviva R, Santangelo R, Cardile V, Barbagallo I, Abraham NG, Sorrenti V.
Int J Oncol. 2011 Nov;39(5):1303-10. doi: 10.3892/ijo.2011.1107. Epub 2011 Jun 30.
Identifying differences between biochemical failure and cure: incidence rates and predictors.
Vicini FA, Shah C, Kestin L, Ghilezan M, Krauss D, Ye H, Brabbins D, Martinez AA.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e369-75. Epub 2011 Jul 19.
Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion.
Shimizu S, Osaka Y, Shinohara N, Sazawa A, Nishioka K, Suzuki R, Onimaru R, Shirato H.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e393-9. Epub 2011 Jun 12.
Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
Zilli T, Taussky D, Donath D, Le HP, Larouche RX, Béliveau-Nadeau D, Hervieux Y, Delouya G.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e377-83. Epub 2011 Apr 20.
Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate.
Winkfield KM, Chen MH, Dosoretz DE, Salenius SA, Katin M, Ross R, D'Amico AV.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e345-50. Epub 2011 Apr 20.
Radiation enhances regulatory T cell representation.
Kachikwu EL, Iwamoto KS, Liao YP, DeMarco JJ, Agazaryan N, Economou JS, McBride WH, Schaue D.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1128-35. Epub 2010 Nov 17.
Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
Boggula R, Jahnke L, Wertz H, Lohr F, Wenz F.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1168-75. Epub 2010 Nov 17.
Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
Mutanga TF, de Boer HC, van der Wielen GJ, Hoogeman MS, Incrocci L, Heijmen BJ.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1160-7. Epub 2010 Oct 29.
Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
Zauls AJ, Ashenafi MS, Onicescu G, Clarke HS, Marshall DT.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1010-6. Epub 2010 Oct 1.
Paraneoplastic neurological and hematological syndromes associated with prostate cancer.
Gakiya M, Naka H, Saito S.
Int J Urol. 2012 May;19(5):471-4. doi: 10.1111/j.1442-2042.2011.02949.x. Epub 2012 Jan 6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on